NTES-S
09999
BOSS ZHIPIN-W
02076
JD HEALTH
06618
TENCENT
00700
ALI HEALTH
00241
(FY)Apr 30, 2024 | (Q6)Oct 31, 2023 | (FY)Apr 30, 2023 | (Q6)Oct 31, 2022 | (FY)Apr 30, 2022 | (Q6)Oct 31, 2021 | (FY)Apr 30, 2021 | (Q6)Oct 31, 2020 | (FY)Apr 30, 2020 | (Q6)Oct 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -44.03%119.77M | ---- | -18.33%213.98M | ---- | -8.93%262.01M | ---- | 57.80%287.7M | ---- | 27.06%182.32M | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -29.91%-7.89M | ---- | -877.62%-6.07M | ---- | 78.69%-621K | ---- | 43.29%-2.91M | ---- | 11.43%-5.14M | ---- |
Interest expense - adjustment | 45.54%25.54M | ---- | 4.93%17.55M | ---- | -17.29%16.72M | ---- | -7.94%20.22M | ---- | 2,558.96%21.96M | ---- |
Dividend (income)- adjustment | ---296K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provisions: | 1.47%1.04M | ---- | -94.17%1.02M | ---- | 649.62%17.53M | ---- | -19.21%2.34M | ---- | --2.89M | ---- |
-Impairmen of inventory (reversal) | 1.47%1.04M | ---- | -94.17%1.02M | ---- | 649.62%17.53M | ---- | -19.21%2.34M | ---- | --2.89M | ---- |
Revaluation surplus: | -61.65%4.49M | ---- | 224.09%11.72M | ---- | 217.37%3.62M | ---- | -177.19%-3.08M | ---- | 261.60%3.99M | ---- |
-Fair value of investment properties (increase) | 246.74%3.26M | ---- | -161.44%-2.22M | ---- | 217.37%3.62M | ---- | -177.19%-3.08M | ---- | 261.60%3.99M | ---- |
-Other fair value changes | -91.15%1.23M | ---- | --13.94M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | 15.64%1.44M | ---- | -10.80%1.25M | ---- | 8.29%1.4M | ---- | -69.20%1.29M | ---- | 1,653.97%4.19M | ---- |
-Loss (gain) on sale of property, machinery and equipment | 15.64%1.44M | ---- | -10.80%1.25M | ---- | 8.29%1.4M | ---- | -69.20%1.29M | ---- | 1,653.97%4.19M | ---- |
Depreciation and amortization: | 6.44%384.6M | ---- | -4.63%361.34M | ---- | -1.35%378.86M | ---- | -1.88%384.05M | ---- | 1,229.51%391.42M | ---- |
-Amortization of intangible assets | 13.12%4.51M | ---- | -0.13%3.99M | ---- | 9.88%3.99M | ---- | 31.58%3.63M | ---- | 316.44%2.76M | ---- |
Special items | 109.83%619K | ---- | 101.03%295K | ---- | 10.23%-28.66M | ---- | -1,105.70%-31.93M | ---- | 193.99%3.18M | ---- |
Operating profit before the change of operating capital | -11.94%529.32M | ---- | -7.65%601.07M | ---- | -1.04%650.85M | ---- | 8.74%657.68M | ---- | 272.53%604.82M | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -385.09%-43.97M | ---- | 179.24%15.42M | ---- | 49.35%-19.46M | ---- | 26.64%-38.42M | ---- | -288.14%-52.38M | ---- |
Accounts receivable (increase)decrease | 125.44%4.76M | ---- | -34.93%-18.69M | ---- | -19,611.27%-13.85M | ---- | 101.37%71K | ---- | 58.61%-5.2M | ---- |
Accounts payable increase (decrease) | 199.89%34.04M | ---- | -1,013.67%-34.08M | ---- | -86.09%3.73M | ---- | 265.90%26.82M | ---- | 188.18%7.33M | ---- |
Cash from business operations | -7.02%524.15M | -16.65%259.34M | -9.26%563.72M | -4.27%311.14M | -3.85%621.27M | -20.30%325.03M | 16.51%646.14M | 41.90%407.81M | 333.30%554.57M | 216.58%287.4M |
Other taxs | -64.94%-57.45M | -20,603.11%-53.21M | -22.56%-34.83M | 86.15%-257K | -27.06%-28.42M | -42.36%-1.86M | -3.80%-22.37M | -830.71%-1.3M | 16.70%-21.55M | -300.00%-140K |
Net cash from operations | -11.76%466.69M | -33.69%206.13M | -10.79%528.89M | -3.80%310.88M | -4.96%592.84M | -20.50%323.17M | 17.03%623.77M | 41.51%406.51M | 421.97%533.02M | 216.18%287.26M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 51.08%7.71M | 163.01%4.86M | 722.22%5.11M | 465.44%1.85M | -78.69%621K | -85.87%327K | -43.29%2.91M | -18.64%2.31M | -11.43%5.14M | -2.87%2.84M |
Dividend received - investment | --296K | --297K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | ---- | ---- | ---- | ---- | --388K | ---- | ---- | ---4K | --4K | ---- |
Sale of fixed assets | -4.87%527K | -9.00%364K | 18,366.67%554K | --400K | -98.51%3K | ---- | 44.29%202K | 250.00%175K | -72.11%140K | -51.46%50K |
Purchase of fixed assets | -104.29%-62.01M | -213.60%-46.86M | -11.34%-30.35M | 9.77%-14.94M | 66.69%-27.26M | 20.91%-16.56M | -160.33%-81.84M | -14.77%-20.94M | -0.58%-31.44M | -91.35%-18.24M |
Purchase of intangible assets | ---2.57M | ---287K | ---- | ---- | 20.00%-1.76M | -184.21%-1.3M | 42.22%-2.21M | ---456K | 57.72%-3.82M | ---- |
Cash on investment | ---- | ---- | ---- | ---- | ---23.31M | ---23.31M | ---- | ---- | ---1.83M | ---1.83M |
Net cash from investment operations | -126.94%-56.03M | -227.91%-41.62M | 51.89%-24.69M | 68.92%-12.69M | 36.58%-51.32M | -115.98%-40.84M | -154.49%-80.92M | -10.10%-18.91M | 6.40%-31.8M | -181.03%-17.17M |
Net cash before financing | -18.55%410.66M | -44.83%164.51M | -6.89%504.2M | 5.61%298.19M | -0.24%541.52M | -27.16%282.34M | 8.31%542.85M | 43.51%387.6M | 635.55%501.22M | 218.72%270.08M |
Cash flow from financing activities | ||||||||||
New borrowing | 212.65%9.46M | 1,547.45%8.82M | ---8.4M | ---609K | ---- | ---- | -106.32%-120K | 218.10%14.11M | -73.01%1.9M | ---11.94M |
Refund | ---- | ---- | ---- | ---- | --2.7M | ---- | ---- | ---- | ---16.6M | ---- |
Issuing shares | ---- | ---- | -50.46%2.03M | -47.51%2.03M | -31.68%4.11M | -32.94%3.88M | 858.53%6.01M | 821.53%5.78M | -81.37%627K | -4.57%627K |
Interest paid - financing | -54.43%-1.1M | -128.42%-434K | -94.79%-711K | -27.52%-190K | 16.09%-365K | 34.07%-149K | 36.50%-435K | 43.50%-226K | 7.81%-685K | -55.04%-400K |
Dividends paid - financing | 34.49%-113.03M | 15.59%-72.73M | 19.62%-172.54M | 20.98%-86.16M | -49.57%-214.66M | -38.05%-109.04M | -37.62%-143.52M | -22.92%-78.98M | -18.26%-104.29M | -27.87%-64.26M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.67M | ---- |
Other items of the financing business | -95.53%-1.18M | ---751K | 94.09%-604K | ---- | -154.80%-10.22M | 102.57%103K | 34.28%-4.01M | -48.33%-4.01M | -11.21%-6.1M | -2,869.23%-2.7M |
Net cash from financing operations | 8.75%-474.43M | -0.99%-247.49M | 5.80%-519.94M | 12.45%-245.05M | -15.23%-551.93M | -25.39%-279.89M | 5.60%-478.99M | 17.60%-223.22M | -502.74%-507.43M | -396.10%-270.89M |
Effect of rate | -103.11%-35K | 54.07%-558K | 199.82%1.13M | -245.17%-1.22M | -160.52%-1.13M | -135.92%-352K | 345.26%1.86M | 527.95%980K | -185.71%-760K | 78.15%-229K |
Net Cash | -305.20%-63.77M | -256.15%-82.98M | -51.22%-15.74M | 2,075.11%53.14M | -116.30%-10.41M | -98.51%2.44M | 1,128.97%63.86M | 20,470.26%164.39M | 61.32%-6.21M | -102.68%-807K |
Begining period cash | -3.50%402.31M | -3.50%402.31M | -2.69%416.92M | -2.69%416.92M | 18.12%428.46M | 18.12%428.46M | -1.88%362.74M | -1.88%362.74M | -4.23%369.7M | -4.23%369.7M |
Cash at the end | -15.86%338.5M | -32.01%318.78M | -3.50%402.31M | 8.89%468.85M | -2.69%416.92M | -18.47%430.55M | 18.12%428.46M | 43.25%528.11M | -1.88%362.74M | -11.19%368.67M |
Cash balance analysis | ||||||||||
Bank deposits | ---- | -40.06%133.59M | ---- | -8.60%222.88M | ---- | -53.82%243.86M | ---- | 43.25%528.11M | ---- | -11.19%368.67M |
Cash and cash equivalent balance | ---- | -40.06%133.59M | ---- | -8.60%222.88M | ---- | -53.82%243.86M | ---- | 43.25%528.11M | ---- | -11.19%368.67M |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.